Sort
48,018 grants matching “immunotherapy”
Leveraging 30 years of Alzheimer's disease clinical trials data to decipher phenotypic response to treatment
$3,281,385Judy Pa · University Of California, San Diego · RF1 · FY2024 · AG
CANCER CENTER SUPPORT GRANT
$3,278,759University Of Colorado Denver · P30 · FY2001 · CA
Graft-versus-leukemia
$3,273,957Austin J Barrett · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
Gene therapy of cancer
$3,270,963Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Adoptive Cell Transfer Immunotherapy of Cancer
$3,270,963Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Branch Clinical Research Core
$3,264,784Ronald Gress · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$3,264,185Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Stanford University Cancer Center
$3,254,335Beverly Shriver Mitchell · Stanford University · P30 · FY2010 · CA
Baylor College of Medicine Cancer Center
$3,253,119C Kent Osborne · Baylor College Of Medicine · P30 · FY2017 · CA
Baylor College of Medicine Cancer Center
$3,253,119C Kent Osborne · Baylor College Of Medicine · P30 · FY2016 · CA
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$3,252,811Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
B7-H3-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL IMMUNOTHERAPY FOR METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC)
$3,246,139The General Hospital Corporation · · FY2020 · Defense Health Agency
COG NCTN Network Group Operations Center - Year 10 STAR Act COG) Outcomes & Survivorship (LTE) Committee
$3,243,049Douglas S. Hawkins · Public Health Institute · U10 · FY2023 · CA
CCR Genomics Core
$3,231,619Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
COMBINING IMMUNOTHERAPY AND MYC SYNTHETIC LETHALITY FOR METASTATIC BREAST CANCER
$3,230,000Regents Of The University Of California, San Francisco, The · · FY2021 · Defense Health Agency
Role of the Retrosplenial Cortex in the Progression of AD Pathogenesis in Mouse and Human
$3,221,450Kevin T Beier · University Of California-Irvine · RF1 · FY2025 · AG
THERAPEUTIC INDEX OF ACUTE LYMPHOBLASTIC LEUKEMIA
$3,219,060Dana-Farber Cancer Institute · P01 · FY2003 · CA
Characterization of Antigen-Specific Immune Response in ALS
$3,213,011Wassim Elyaman · Columbia University Health Sciences · RF1 · FY2025 · NS
CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH CONSORTIUM
$3,210,960University Of California San Diego · P01 · FY2000 · CA
Characterization and Enhancement of Anti-Tumor Immune Responses in Head and Neck Cancer
$3,210,574Clint Allen · National Institute On Deafness And Other Communication Disorders · ZIA · FY2022 · DC
Baylor College of Medicine Cancer Center
$3,203,119C Kent Osborne · Baylor College Of Medicine · P30 · FY2019 · CA
Mechanisms of Fecal Microbiota Transplant Protection from Recurrent C. difficile
$3,202,592William A Petri · University Of Virginia · R01 · FY2025 · AI
Statistics Core for SWOG SDMC
$3,197,895Michael Leo Leblanc · Fred Hutchinson Cancer Center · U10 · FY2022 · CA
B-Lymphocyte Immunotherapy in Islet Transplantation
$3,195,859University Of Pennsylvania · U01 · FY2004 · DK
Maternal Immunization and Determinants of Infant Immunity
$3,188,570Marcela F Pasetti · University Of Maryland Baltimore · U19 · FY2021 · AI